Cancer- and treatment-related anemia: Clinical Practice Guidelines in Oncology

George M. Rodgers, David Cella, Asher Chanan-Khan, Carolyn Chesney, Charles Cleeland, Peter F. Coccia, George D. Demetri, Benjamin Djulbegovic, Jennifer L. Garst, Margaret Gore, Eric H. Kraut, Weei Chin Lin, Michael Millenson, Victoria Mock, Denise Reinke, Joseph Rosenthal, Paul Sabbatini

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Abstract

Cancer- and treatment-related anemia has received increasing attention, particularly because relationships between anemia and quality of life (QOL) or treatment outcomes are under investigation. This guideline recognizes the multiple etiologies of cancer- and treatment-related anemia, but specifically addresses the treatment of anemia caused by the myelosuppressive effects of chemotherapy and the anemia associated with chronic disease. It provides guidelines for the use of erythropoietic agents in patients with cancer who are receiving chemotherapy.

Original languageEnglish (US)
Pages (from-to)772-789
Number of pages18
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume3
Issue number6
DOIs
StatePublished - Nov 2005

Keywords

  • Anemia
  • Chemotherapy
  • Darbapoetin
  • Epoetin
  • Erythropoietin
  • Ferric gluconate
  • Heme iron polypeptide
  • Hemoglobin
  • Iron dextran
  • Iron sucrose
  • NCCN Clinical Practice Guidelines in Oncology
  • Quality of life
  • Serum ferritin

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Cancer- and treatment-related anemia: Clinical Practice Guidelines in Oncology'. Together they form a unique fingerprint.

Cite this